Equate Cold Therapy Pain Relieving

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains. It provides symptomatic relief for arthritis, back pain, and soreness in muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended dosage is to spray the medication on the affected area up to four times daily. It is important to ensure that the application does not exceed this frequency to avoid potential adverse effects.

For children under 12 years of age, it is advised to consult a physician prior to use to determine the appropriate dosage and administration guidelines tailored to the child's specific needs.

Contraindications

Contact with the eyes or mucous membranes should be avoided. Application to wounds or damaged skin is contraindicated. The product should not be applied to irritated skin or if excessive irritation develops. Additionally, do not bandage tightly or use in conjunction with a heating pad or device.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from excessive heat or open flame.

General precautions must be observed to ensure safe use. Contact with the eyes or mucous membranes should be avoided. The product should not be applied to wounds or damaged skin, nor should it be used on irritated skin or if excessive irritation develops. Additionally, it is advised not to bandage tightly or use in conjunction with a heating pad or device.

Healthcare professionals should instruct patients to stop use and seek medical advice if they experience pain, swelling, or blistering of the skin. Patients should also be advised to contact their doctor if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

In the event of ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and is flammable; therefore, it should be kept away from excessive heat or open flame.

During use, patients should avoid contact with the eyes and mucous membranes. It is advised not to apply the product to wounds or damaged skin, and to refrain from using it on irritated skin or if excessive irritation develops. Additionally, patients should not bandage the area tightly or use the product in conjunction with a heating pad or device.

Patients are instructed to stop using the product and consult a doctor if they experience pain, swelling, or blistering of the skin. They should also seek medical advice if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Cold Therapy Pain Relieving (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use the product by spraying it on the affected area up to four times daily. For children under 12 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data may impact the drug's efficacy and safety profile in this population. Regular monitoring of renal function is advisable to ensure patient safety.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience any pain, swelling, or blistering of the skin. Additionally, they should be advised to stop using the product and seek medical advice if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

While using this product, patients must be cautioned to avoid contact with the eyes and mucous membranes. They should not apply the product to wounds or damaged skin, nor should they use it on irritated skin or if excessive irritation develops. Furthermore, patients should be instructed not to bandage the area tightly or use it in conjunction with a heating pad or device.

Storage and Handling

The product is supplied in packaging that adheres to the National Drug Code (NDC) specifications. It is essential to store the product at a temperature range of 20-25°C (68-77°F). Additionally, it should be kept in a cool, dry place, away from direct sunlight to maintain its integrity and efficacy. Proper storage conditions are crucial for ensuring the product's quality throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Equate Cold Therapy Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)